28 results on '"Chernyaeva, E. V."'
Search Results
2. Influence of the Polymer Layers of Protecting Structures on the Acoustic Emission Parameters
3. Interference of Factors in the Competitive Interaction of the Alien Species Pulmonaria saccharata (Mill) with a Seed Bank in the Conditions of Introduction
4. Study of the Acoustic Emission and Calorimetric Properties of Titanium Nickelide after Barocryodeformation
5. Estimation of the Barocryodeformation Effect on the Microstructure and Mechanical Properties of Copper
6. Structure formation upon barocryodeformation of a steel of austenitic class
7. Differential Diagnostics of Toxic Epidermal Necrolysis (Lyell’s Syndrome) in ICU: Case Reports
8. Acoustic emission in commercial titanium after barocryodeformation
9. Influence of barocryodeformation conditions on the properties of VT1-0 titanium alloy
10. Evaluation of the condition of a metal using the acoustic-emission method: Prospects and problems
11. Influence of barocryodeformation on the hydrogen concentration and acoustic emission in VT1-0 commercial titanium
12. “Natural” hydrogen and acoustic emission in Kh18N10T steel after barocryodeformation
13. Research into Antibacterial Activity of Novel Disinfectants Derived from Polyhexamethylene Guanidine Hydrochloride
14. Use of the method of acoustic emission for determining the mechanical properties of pipe steels
15. Efficacy and safety of a new original interleukin 17A inhibitor in the treatment of patients with active ankylosing spondylitis: results of a basic (BCD-085-3/AILAS) and extended (BCD-085-3ext/AILAS-II) phase II clinical trial
16. Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext
17. Effect of Severe Plastic Deformation on the Acoustic Emission and the Thermal Effects in Titanium Nickelide
18. INTRODUCTION SOME FOREST PERENNIAL SPECIES IN A METROPOLIS
19. Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis
20. Comparative efficacy and safety of adalimumab biosimilar (BCD-057) and innovator in patients with psoriasis vulgaris. Results of the BCD-057-2/CALYPSO phase III international, multicenter, randomized double-blind clinical trial
21. Интродукция некоторых лесных многолетников в условиях мегаполиса
22. COMPARATIVE EVALUATION OF THE LONG-TERM EFFICACY AND SAFETY OF THE INFLIXIMAB BIOSIMILAR BCD-055 AND REFERENCE INFLIXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS OF THE INTERNATIONAL MULTICENTER RANDOMIZED DOUBLE-BLIND PHASE III CLINICAL STUDY ASART-2
23. Acoustic emission during the thermal cycling of titanium nickelide under conditions of uneven heating
24. THE EFFICACY AND SAFETY OF RITUXIMAB BIOSIMILAR (ACELLBIA®) IN RHEUMATOID ARTHRITIS AS THE FIRST BIOLOGICAL AGENT: RESULTS OF PHASE III (ALTERRA) CLINICAL TRIAL
25. Comparative efficacy and safety of infliximab biosimilar (BCD-055) and innovator infliximab in patients with ankylosing spondylitis (results of international, multiple-center, double-blind phase I and phase III clinical studies)
26. DEVELOPMENTS OF RUSSIAN ORIGINAL BIOLOGICAL AGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY RHEUMATIC DISEASES
27. THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY)
28. CURRENT APPROACH TO DEVELOPMENT OF BIOSIMILAR PRODUCTS CONTAINING MONOCLONAL ANTIBODIES AS AN ACTIVE SUBSTANCE – NON-CLINICAL AND CLINICAL STUDIES OF THE FIRST RUSSIAN RITUXIMAB BIOSIMILAR, ACELLBIA®
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.